Editor of Patient Care Online.
FDA Approves Ensifentrine for Maintenance Treatment of COPD in Adults: Daily Dose
Your daily dose of the clinical news you may have missed.
More Than 60% of US Adults Unaware Primary Care Clinicians Can Prescribe Medications for Opioid Use Disorder
Findings from a national survey also showed that Black respondents were most likely to believe they could not receive medications for OUD at a PCP.
Aspirin Still Used for Primary Prevention among Older Americans Without CVD: Daily Dose
Workplace Sexual Harassment Tied to Higher Risk of CVD, T2D in Men and Women
The risk for developing CVD and T2D was highest among individuals who frequently experienced the behavior in the workplace, according to new study.
Sex Disparities in Long-Term Lipid Management: Daily Dose
CDC Updates COVID-19, Influenza Vaccine Recommendations for 2024-2025 Respiratory Virus Season
Individuals 6 months and older should receive updated COVID-19 and influenza vaccines for the 2024-2025 respiratory virus season, the agency recommended.
Prevalence of Chronic HTN During Pregnancy in US: Daily Dose
SECURE-T2D: Automated Insulin Delivery System Reduced A1c in Adults with Type 2 Diabetes
ADA 2024. Adults started on the Omnipod 5 AID system had an A1c reduction from 8.2% at baseline to 7.4% at 13 weeks, researchers report.
Racial Disparities in Cardiovascular Disease Outcomes: Daily Dose
One-Quarter of Adults with Difficult-to-Control T2D have Hypercortisolism, According to New Data
ADA 2024. Adults using more antihypertensive medications had higher odds for hypercortisolism, according to new data from the CATALYST phase 4 study.
Dapagliflozin Approved for Treatment of T2D in Children: Daily Dose
FLOW Trial: Semaglutide Lowers Risk for Major Kidney Disease, CV Events and Death Regardless of SGLT-2i Use
ADA 2024. Semaglutide benefits were observed for adults with type 2 diabetes and chronic kidney disease whether or not they used SGLT-2 inhibitors, according to an analysis of FLOW trial data.
Sugar Substitute Raises Risk of Major Adverse Cardiovascular Events: Daily Dose
SURMOUNT-OSA: Tirzepatide Improves Sleep Apnea Symptoms, CV Outcomes in Adults with OSA and Obesity
ADA 2024. Adults with OSA and obesity receiving tirzepatide had improvements in sleep apnea severity and systolic blood pressure compared to placebo.
Global Prevalence of T1D Rising in Older Adults: Daily Dose
ADA 84th Scientific Sessions: 3 Studies Primary Care Clinicians Should Put on Their Radar
Details on tirzepatide for obesity-related obstructive sleep apnea, semaglutide for prevention of major kidney outcomes in patients with T2D and CKD, more.
Investigational Influenza-COVID-19 Combination Vaccine Elicits Immune Response in Older Adults: Daily Dose
New Report Shows that Despite Gains, Black Americans Still Face Higher Cardiovascular Mortality
Between 2000 and 2022, there were nearly 800 000 excess CV deaths among Black Americans and 24 million additional years of life lost, researchers report.
Investigational RNAi Agent Cuts Triglyceride Levels in Patients with Mixed Hyperlipidemia: Daily Dose
ADA 84th Scientific Sessions Preview: STEP-HFp-EF Trial Data, Tirzepatide for Obesity-Related OSA, Optimizing Diabetes Care in Primary Care
Find details on optimizing diabetes care in primary care settings, benefits of GLP-1RAs for patients with HF and diabetes, and tirzepatide use for obesity-related OSA.
Tirzepatide Superior to Placebo in MASH Resolution, Fibrosis Improvement: Daily Dose
Type 1 Diabetes in Older Adults Nearly Tripled in 3 Decades, According to New Data
Global prevalence of adults 65 years and older with T1D increased 180% in the past 30 years, researchers reported.
Adolescent Obesity Linked to Higher Stroke Risk in Women: Daily Dose
Tirzepatide Found Superior to Placebo in MASH Resolution, Fibrosis Improvement
More than 50% of patients with MASH receiving 1 of 3 doses of tirzepatide achieved MASH resolution without worsening of fibrosis vs placebo, according to data from phase 2 study.
US Drug Overdose Deaths Declined for First Time in 5 Years: Daily Dose
FDA Grants EUA for OTC Triple Test for COVID-19, Influenza A & B: Daily Dose
Impact of Social Stigma on Mental Health among Women with Obesity: An Expert’s View
Shagun Bindlish, MD, board member of the ADA, discusses how societal weight-related stigma contributes to mental health challenges faced by women with obesity.
Women with Overweight/Obesity as Teens, Young Adults Face Higher Risk of Cerebrovascular Disease Later in Life
In contrast, men did not face the same increased risk of cerebrovascular disease later in life, reported authors of a new study.
Two Medication Classes Reduce CV, Liver Events in Persons with T2D, MASLD: Daily Dose
Abbott Secures FDA Clearance for OTC CGMs for General Public, Adults with T2D Who do not Use Insulin
Abbott becomes the second company to receive FDA clearance for an over-the-counter continuous glucose monitoring system.